Human VEGF165b Antibody Summary
TCRSLTRKD
Accession # AAL27435
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
VEGF165bin Human Placenta. VEGF165bwas detected in immersion fixed paraffin-embedded sections of human placenta using Mouse Anti-Human VEGF165bMonoclonal Antibody (Catalog # MAB3045) at 15 µg/mL overnight at 4 °C. Tissue was stained using the Anti-Mouse HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS002) and counterstained with hematoxylin (blue). Specific staining was localized to syncytiotrophoblasts. View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.
VEGF expression determined by Western blot VEGF expression determined by Western blot and immunoprecipitation.A. Western blot using LiCor Odyssey to simultaneously image pan-VEGF and VEGF-A165b probed western blot. Two different podocyte samples, and a primary RPE sample were run on a gel and probed with antibodies to VEGF-A165b (mouse monoclonal anti-CTRSLTRKD, and 680nm-donkey anti-mouse, top image) and pan-VEGF (rabbit polyclonal anti-VEGF, and 800nm-donkey anti-rabbit, middle image). The bottom image is the pseudocoloured combined image (600nm green, 800nm red). Note the red VEGF165, but yellow VEGF-A165b. MWM = molecular weight marker. d = dimer, m = monomer. B. Protein extracted from human cell lines (adenoma and adenocarcinoma(AC)) subjected to immunoprecipitation (IP) for VEGF-A165b and immunoblotting (IB) for total VEGF-A. A clear strong band was seen in the IP for both cell types at ∼23kDa and ∼46kDa, consistent with the IP for recombinant human VEGF-A165b. A weaker band was seen in the input protein (not subjected to IP), and a second band slightly higher in the AC. A weak band at approximately 56kDa and 28kDa was seen in all lanes subjected to IP, including the VEGF-A165a band, but not seen in the recombinant human VEGF-A165b not subjected to IP, indicating that this is cross reactivity with the IgG. This band was clearly above the VEGF-A165b bands. C. Protein extracted from human cell lines (adenoma and adenocarcinoma(AC)) subjected to immunoprecipitation (IP) for VEGF-A and immunoblotting (IB) for VEGF-A165b. A clear strong band was seen in the IP for both cell types at ∼23kDa, the same size as recombinant human VEGF-A165b. In the input a band at ∼46Da was seen predominantly, for both cell types, labelled as VEGF-A165b dimers. D. Mouse tissues probed with VEGF-A165b antibody detect mouse IgG due to the secondary antibody. Top image, western blot of mouse tissues, recombinant mouse IgG or human VEGF-A165b or VEGF-A165b probed with mouse anti-CTRSLTRKD, and 680nm-donkey anti-mouse IgG. Bottom image blot of same tissues, probed without primary antibody. The same bands are seen in the mouse tissues. Spl = spleen, Col = colon, Hrt = heart, Lng = lung, Liv = liver, Kid = kidney. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/23935865), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: VEGF
VEGF165b is the protein resulting from an mRNA splice variant of VEGF. Alternative exon usage results in a 165 amino acid product that is identical to VEGF165 except for 6 unique amino acids at the C-terminus. VEGF165b inhibits proliferation and migration of endothelial cells and is down-regulated in renal cell carcinomas.
Product Datasheets
Citations for Human VEGF165b Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
23
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF165 and downregulating VEGF165b
Authors: Quan, B;Li, Z;Yang, H;Li, S;Yan, X;Wang, Y;
Heliyon
Species: Human
Sample Types: Tissue Homogenates
Applications: Western Blot -
FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells
Authors: T Jia, T Jacquet, F Dalonneau, P Coudert, E Vaganay, C Exbrayat-H, J Vollaire, V Josserand, F Ruggiero, JL Coll, B Eymin
Bmc Biology, 2021-08-25;19(1):173.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
The Production of Pro-angiogenic VEGF-A Isoforms by Hypoxic Human NK Cells Is Independent of Their TGF-beta -Mediated Conversion to an ILC1-Like Phenotype
Authors: Lindsey G. Hawke, Mara K. M. Whitford, Mark L. Ormiston
Frontiers in Immunology
-
Contribution of the VEGF system to the follicular persistence associated with bovine cystic ovaries
Authors: AF Stassi, F Gasser, MML Velázquez, EM Belotti, NC Gareis, F Rey, HH Ortega, NR Salvetti, ME Baravalle
Theriogenology, 2019-07-03;138(0):52-65.
Species: Bovine, Mouse
Sample Types: Cell Lysates, Tissue Homogenates, Whole Tissue
Applications: IHC, IHC-P, Western Blot -
Overexpression of Antiangiogenic Vascular Endothelial Growth Factor Isoform and Splicing Regulatory Factors in Oral, Laryngeal and Pharyngeal Squamous Cell Carcinomas
Authors: Patrícia Matos Biselli-Chicote, Joice Matos Biselli, Bianca R Cunha, Rodrigo Castro, José Victor Maniglia, Dalísio de Santi Neto et al.
Asian Pac. J. Cancer Prev
-
WNT5A regulates adipose tissue angiogenesis via antiangiogenic VEGF-A165b in obese humans
Authors: Shakun Karki, Doan T. M. Ngo, Melissa G. Farb, Song Young Park, Samantha M. Saggese, Naomi M. Hamburg et al.
American Journal of Physiology-Heart and Circulatory Physiology
-
Clinicopathological implications of vascular endothelial growth factor 165b expression in oral squamous cell carcinoma stroma
Authors: MASAHIRO NAGASAKI, SEIJI KONDO, YOSHIKI MUKUDAI, TAKAAKI KAMATANI, AYAKO AKIZUKI, ATSUSHI YASO et al.
Oncology Reports
-
The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis.
Authors: Kim H, Kim K, Kim B, Cho M, Lee S
PLoS ONE, 2015-04-20;10(4):e0124909.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy
Authors: James G. Carter, Melissa V. R. Gammons, Gopinath Damodaran, Amanda J. Churchill, Steven J. Harper, David O. Bates
Angiogenesis
-
Antiangiogenic Actions of Vascular Endothelial Growth Factor-A 165 b, an Inhibitory Isoform of Vascular Endothelial Growth Factor-A, in Human Obesity
Authors: Doan T.M. Ngo, Melissa G. Farb, Ryosuke Kikuchi, Shakun Karki, Stephanie Tiwari, Sherman J. Bigornia et al.
Circulation
-
The role of VEGF-A165b in trophoblast survival.
Authors: Bills V, Hamdollah-Zadeh M, Soothill P, Harper S, Bates D
BMC Pregnancy Childbirth, 2014-08-15;14(0):278.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Bone marrow-derived cells are implicated as a source of lymphatic endothelial progenitors in human breast cancer.
Authors: Van't Hull E, Bron S, Henry L, Ifticene-Treboux A, Turrini R, Coukos G, Delaloye J, Doucey M
Oncoimmunology, 2014-06-25;3(0):e29080.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Detection of VEGF-A(xxx)b isoforms in human tissues.
Authors: Bates, David O, Mavrou, Athina, Qiu, Yan, Carter, James G, Hamdollah-Zadeh, Maryam, Barratt, Shaney, Gammons, Melissa, Millar, Ann B, Salmon, Andrew H, Oltean, Sebastia, Harper, Steven J
PLoS ONE, 2013-07-31;8(7):e68399.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Metastasis of Breast Tumor Cells to Brain Is Suppressed by Phenethyl Isothiocyanate in a Novel In Vivo Metastasis Model
Authors: Parul Gupta, Chris Adkins, Paul Lockman, Sanjay K. Srivastava
PLoS ONE
-
Combined Transfer of Human VEGF165 and HGF Genes Renders Potent Angiogenic Effect in Ischemic Skeletal Muscle
Authors: Pavel Makarevich, Zoya Tsokolaeva, Alexander Shevelev, Igor Rybalkin, Evgeny Shevchenko, Irina Beloglazova et al.
PLoS ONE
-
Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms
Authors: Jeanette Woolard, William Vousden, Steven J. Moss, Arjun Krishnakumar, Melissa Vr Gammons, David G Nowak et al.
Chem. Sci.
-
Recombinant Human VEGF165b Inhibits Experimental Choroidal Neovascularization
Authors: Jing Hua, Christine Spee, Satoru Kase, Emma S. Rennel, Anette L. Magnussen, Yan Qiu et al.
Investigative Opthalmology & Visual Science
-
VEGF-A165b Is Cytoprotective and Antiangiogenic in the Retina
Authors: Anette L. Magnussen, Emma S. Rennel, Jing Hua, Heather S. Bevan, Nicholas Beazley Beazley Long, Christina Lehrling et al.
Investigative Opthalmology & Visual Science
-
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
Authors: Merdzhanova G, Gout S, Keramidas M, Edmond V, Coll JL, Brambilla C, Brambilla E, Gazzeri S, Eymin B
Oncogene, 2010-07-19;29(39):5392-403.
Species: Human
Sample Types: Cell Culture Supernates
Applications: Western Blot -
VEGF in the lung: a role for novel isoforms.
Authors: Varet J, Varet, Julia, Douglas SK, Douglas, Samantha, Gilmartin L, Gilmartin, Laura, Medford, Andrew R, Bates, David O, Harper, Steven J, Millar, Ann B
Am J Physiol Lung Cell Mol Physiol, 2010-03-12;298(6):L768-74.
Species: Human
Sample Types: BALF, Tissue Homogenates, Whole Tissue
Applications: ELISA Development, IHC-P, Western Blot -
VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo.
Authors: Rennel ES, Varey AH, Churchill AJ, Wheatley ER, Stewart L, Mather S, Bates DO, Harper SJ
Br. J. Cancer, 2009-08-25;101(7):1183-93.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.
Authors: Bates DO, MacMillan PP, Manjaly JG, Qiu Y, Hudson SJ, Bevan HS, Hunter AJ, Soothill PW, Read M, Donaldson LF, Harper SJ
Clin. Sci., 2006-05-01;110(5):575-85.
Species: Human
Sample Types: Tissue Homogenates, Whole Tissue
Applications: ELISA Development, IHC-P, Western Blot -
Higher level of acute serum VEGF and larger infarct volume are more frequently associated with post-stroke cognitive impairment
Authors: A Prodjohard, AN Vidyanti, NA Susianti, Sudarmanta, S Sutarni, I Setyoprano
PLoS ONE, 2020-10-05;15(10):e0239370.
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human VEGF165b Antibody
Average Rating: 5 (Based on 2 Reviews)
Have you used Human VEGF165b Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by: